What We Do: Elevate
We are all stronger together.
Our mission is to advance human health worldwide by forging stronger alliances between innovators, industry and government. We believe that partnering with those who share our passion for innovation raises the tide for all participants in the medtech ecosystem and results in the best outcomes for patients and providers worldwide.
We are compelled to use our voice to inform and influence decisions that encourage innovation, drive progress in developing solutions that address unmet clinical needs and benefit early-stage medtech startups. We actively provide perspectives on global health policy issues of concern to innovators, providers and patients and help shape such policy through informed representation.
We insist that the solutions we create be cost-effective and accessible to all patients in need. This is not always the easy way, but it is the right way. We are committed to applying a diversity of perspectives, experiences and backgrounds to clinical challenges because these inevitably shape better results.
“Fogarty Innovation has a unique capability to form partnerships and bridge-build between groups that don’t traditionally work well with others.”
– Physician entrepreneur
We establish effective partnerships by aligning with organizations, institutions, clinical practices, funders and agencies that broaden our reach and share our values. Our most active alliances include:
Stanford Byers Center for Biodesign
There has been a long-standing affiliation between our two organizations as we are both dedicated to accelerating the translation of concepts into viable medical technology businesses. In fact, Stanford Biodesign’s mission,
Educating and empowering health technology innovators, and leading the transition to a value-driven innovation ecosystem
closely reflects our own. Sharing the same philosophy that medical technology innovation must be rooted in filling unmet clinical needs rather than simply pushing technology, Stanford Biodesign and Fogarty Innovation have long collaborated on many fronts. Fogarty staff is involved in the selection of Biodesign Fellows who later often apply to join our Company-in-Residence or Summer Extension programs. Many Fogarty educational programs are also open to Biodesign Fellows. Biodesign, in turn, hosts the annual Thomas J. Fogarty, MD, Lecture and invites Fogarty staff to be involved in many ongoing activities, including offering educational lectures and participating on technology assessment panels.
Both management teams collaborate on critical societal and policy issues that impact the early-stage medtech innovation ecosystem. Diversity by Doing Healthtech (DxD) is the latest example of a joint initiative to raise awareness of inequity in our industry, help individuals take action to create a more just and inclusive environment, and share the results over time.
El Camino Health (ECH)
It is entirely fitting that Fogarty Innovation is housed on the Mountain View hospital campus of El Camino Health, occupying an entire floor of one of its newest buildings—The Sobrato Pavilion. El Camino Health continues to be on the leading edge of integrating technology into practice, starting with its 1971 partnership with Lockheed to implement the world’s first electronic medical information system. Today, El Camino Health’s spirit to drive meaningful change in medicine continues through the work of the Taft Center for Clinical Research, which offers patients the opportunity to take part in the latest research studies. Our residency at El Camino Health dates back to 2007. Numerous Fogarty innovators have received practical, hands-on experience and education in clinical and administrative settings, ensuring that real-world issues faced by providers are addressed by their inventions. Physicians at El Camino Health have been attracted to Fogarty Innovation’s invention accelerator program, working with our staff to bring to life ideas that benefit the practice of medicine. El Camino Health and Fogarty Innovation continue to seek ways to collaborate to introduce more joint programs in the future.
Among those in our growing list of alliances are:
Government Agency Collaboration
U.S. Food & Drug Administration (FDA)
Through our longstanding FDA Fellowship program, senior leaders from the agency embed themselves within Fogarty Innovation for an intense week of learning. The program, which takes place several times a year, fosters collaboration between entrepreneurs and regulators that elevates understanding on both sides: regulators better appreciate the challenges of device development, and Fogarty entrepreneurs better comprehend the requirements of the regulatory process. Thanks to these insights, the FDA has made significant enhancements to its process, thus accelerating the delivery of life-saving technologies to patients.
Centers for Medicare & Medicaid Services (CMS)
We actively collaborate with the Medical Device Manufacturers Association (MDMA), a beacon in our industry, to help solve the top challenges facing medical technology companies. Among the most important of those efforts, is to create a dialogue with CMS to ease the process of obtaining reimbursement for new medical devices.
A prolific publisher and organizer of stimulating industry conferences that have helped medical device industry executives better understand ever-changing medtech dynamics, Medtech Strategist (MTS) is a powerful voice that has helped shaped the ecosystem for the last two decades. Fogarty Innovation is proud to be a co-organizer and active facilitator in MTS’ high-impact conferences, which bring together industry thought-leaders, investors and innovators from around the globe.
Based in Washington D.C., MDMA is the leading voice representing the interests of smaller, innovative and entrepreneurial medical technology companies. By providing educational and advocacy assistance to member companies, MDMA shares a similar mission to Fogarty Innovation. We have partnered consistently with MDMA to help influence policy affecting early-stage medtech companies. MDMA’s President and CEO, Mark Leahy, is an active member of Fogarty Innovation’s board of directors. MDMA also co-sponsors the Diversity, Equity, Inclusion, and Belonging seminar series organized by DxD.
Diversity by Doing (DxD)
Fogarty Innovation teamed with the Stanford Byers Center for Biodesign and industry leaders in 2019 to examine barriers to diversity within management ranks of small- to medium-size medtech corporations. This resarch led to the creation of Diversity by Doing HealthTech (DxD), an action-oriented program that empowers diversity change agents by providing education, expert voices, and practical resources.
Learn more about DxD’s programs for companies and individuals, including speed mentoring, the Summer Innovation Series for college-age interns from underrepresented groups, the DEIB seminar series for healthtech leaders, and more. DxD is led by executive director Ingrid Ellerbe.
Fogarty Innovation has collaborated with MedtechWomen for many years and plays a significant role in select programs like the Ferolyn Fellowship, which is highlighted at the yearly meeting for MedtechWomen, Medtech Vision. More recently, we introduced the organization to the research findings and resources of Diversity by Doing Healthtech (DxD). We are actively seeking to deepen this alliance going forward.
Boys & Girls Clubs of the Peninsula
Fogarty Innovation works witth neighbors on the San Francisco Peninsula to ensure that youth from all socio-economic brackets in our community are able to learn about and get involved in opportunities in medtech and healthcare. We are pleased to include candidates from the Boys & Girls Clubs of the Peninsula (BGCP) in our Lefteroff summer internship program for college students and are excited about additional opportunities to work together.
Other Global Innovation Programs
The UCSF Rosenman Institute
Fogarty staff and our Companies-in-Residence have interacted with The UCSF Rosenman Institute for a number of years, driven by our common networks and interest in advancing early-stage medtech innovation. More recently, the organizations have aligned to benefit entrepreneurs working on the northern and southern ends of the San Francisco Peninsula. Some important educational programming is now open to cross registration for CEOs at either organization.
Fogarty Innovation works with the Singapore Biodesign (SB) program to introduce the Silicon Valley medtech ecosystem. Teams of Fellows from the SB Innovation and Faculty Fellowship programs are introduced to mentors at FI who help assess the projects they are pursuing and offer strategic guidance. Additionally, the Fellows are introduced to Company-in-Residence teams and outside experts who provide additional insights about the experience of being a startup company in one of the most competitive medtech environments.
The BOLT Initiative
The BOLT Initiative is a competitive, invitation-only curriculum, open to individuals/teams trained through the Singapore Biodesign process. The program provides mentoring and networking to the selected teams to assist them with advancing their innovation toward delivery to patients and their families. Each year, one of the selected teams may participate in an in-person mentoring experience in the Silicon Valley.
University of California San Francisco (UCSF) / Stanford Pediatric Device Consortium (PDC)
With an aim to improve the health, safety and quality of life of pediatric patients by accelerating high-value, high-impact pediatric device solutions towards commercialization, the UCSF-Stanford Pediatric Device Consortium has combined the research and translational expertise of the two institutions. The organization incorporates the unique innovation methodology of Stanford Biodesign, whose model for device development is world renowned. Fogarty staff is active on the advisory board and participates yearly as judges in the PDC accelerator Shark Tank competition, which awards seed funding to companies developing meaningful pediatric solutions in this often-overlooked space.
The Investment Community
Over their years of experience within the industry, members of the Fogarty team have forged extensive relationships with venture capital and angel funds, among other types of investors. We are actively growing those relationships, reaching out to new investors, and exploring new investment vehicles alongside those who are interested in the work of value creation and innovation in healthcare.